| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5503196 | Journal of the Neurological Sciences | 2017 | 42 Pages |
Abstract
Ten NOAC users developed major bleeding and were given relatively low doses of PCC. The effect of PCC on early cessation of bleeding was unclear, while the therapy did not trigger thromboembolic complications.
Keywords
RCCESUSNVAFNOACPT-INRVKAFFPNIHSSTIAIQRMRSCCRPCCAPTTvitamin K antagonistprothrombin complex concentratetransient ischemic attackintracerebral hemorrhagemajor bleedingactivated partial thromboplastin timeRed cell concentratesStrokeembolic stroke of undetermined sourcebody mass indexBMInon-vitamin K antagonist oral anticoagulantNon-vitamin K antagonist oral anticoagulantsAtrial fibrillationNonvalvular atrial fibrillationNational Institutes of Health stroke scaleinterquartile rangeModified Rankin scaleinternational normalized ratio of prothrombin timefresh frozen plasma
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Sohei Yoshimura, Shoichiro Sato, Kenichi Todo, Yasushi Okada, Eisuke Furui, Takayuki Matsuki, Hiroshi Yamagami, Masatoshi Koga, Jun C. Takahashi, Kazuyuki Nagatsuka, Shoji Arihiro, Kazunori Toyoda,